The article presents the experience of using peritonectomy with intraperitoneal hyperthermic chemophoresis (NIPEC) in peritoneal lesions of the peritoneum in patients with ovarian cancer. The annual survival rate for cervical cancer was 88.6%, for ovarian cancer — 85.2%, for uterine body cancer — 79.1%. The results of three and five years of survival were 31% and 14% for cervical cancer; 18% and 9% — for ovarian cancer; 38% and 18% — for uterine body cancer, respectively. There were no systemic complications. Complications following the conduct of the HIPEC were bleeding into the abdominal cavity — in 1 (0.1%) and perforation of the small intestine — in 1 (0.1 %) cases. There was no postoperative lethality.
